(Q47218179)

11 January 2018

title

Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus (English)

1 reference

11 January 2018

0 references

0 references

1 reference

K Fujioka

1

1 reference

11 January 2018

T B Seaton

2

1 reference

11 January 2018

E Rowe

3

1 reference

11 January 2018

C A Jelinek

4

1 reference

11 January 2018

P Raskin

5

1 reference

11 January 2018

H E Lebovitz

6

1 reference

11 January 2018

S P Weinstein

7

1 reference

11 January 2018

Sibutramine/Diabetes Clinical Study Group

8

1 reference

11 January 2018

publication date

1 June 2000

1 reference

11 January 2018

Diabetes, Obesity and Metabolism

published in

1 reference

11 January 2018

volume

2

1 reference

11 January 2018

issue

3

1 reference

11 January 2018

page(s)

175-187

1 reference

11 January 2018

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Diabetes in America: epidemiology and scope of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

The prevention and treatment of obesity. Application to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Long-term effects of modest weight loss in type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Nutrition principles for the management of diabetes and related complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Diabetic diets and nutritional recommendations: what happens in real life?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

The comparison of four weight reduction strategies aimed at overweight diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

The contribution of metabolites to the rapid and potent down-regulation of rat cortical beta-adrenoceptors by the putative antidepressant sibutramine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Sibutramine produces dose-related weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Assessing Impact of Weight on Quality of Life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

An analysis of variance test for normality (complete samples)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Diet Therapy of Diabetes: An Analysis of Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Sibutramine. A review of its contribution to the management of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-dependent diabetic and nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

The Safety and Efficacy of a Controlled Low-Energy ('Very-Low-Calorie') Diet in the Treatment of Non-Insulin-Dependent Diabetes and Obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Type II diabetic subjects lose less weight than their overweight nondiabetic spouses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Relationship of body fat distribution pattern to atherogenic risk factors in NIDDM. Preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

Average Partial Association in Three-Way Contingency Tables: A Review and Discussion of Alternative Tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2000.00081.X

10.1046/J.1463-1326.2000.00081.X

21 January 2018

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

11220553

1 reference

11 January 2018